Work

Clinical Use of PARP Inhibitors in BRCA Mutant and Non-BRCA Mutant Breast Cancer

Year: 2023

Type: book-chapter

Source: Cancer treatment and research

DOI: 10.1007/978-3-031-30065-3_6

Authors: Filipa Lynce, Mark Robson

Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Dana-Farber Brigham Cancer Center, Memorial Sloan Kettering Cancer Center

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4388778438

FWCI: 3.841

Cites: 34

Cited by: 5

Related to: 10